Benzinga | Aug 6, 2020 09:29AM EDT

Catalyst Biosciences Earlier Reported Q2 EPS $(0.96) Up From $(1.15) YoY

Catalyst Biosciences (NASDAQ:CBIO) reported quarterly losses of $(0.96) per share. This is a 16.52 percent increase over losses of $(1.15) per share from the same period last year.